Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852780) titled 'Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Tanta University

Condition: Sepsis

Intervention: Drug: Placbo

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: October 1, 2026

Target Sample Size: 66

To know more, visit https://clinicaltrials.gov/study/NCT07852780

Published by HT Digital Cont...